Table 4 reports the additional significant differences found in the comparison between T2DM patients and control subjects, showing more abnormalities in the following serum biomarkers and vital parameters among T2DM patients, as expected: HbA1c (glycated hemoglobin), vitamin D, vitamin B12, calcium, HDL, fasting blood glucose, creatinine, triglyceride, uric acid, ferritin, TSH (thyrotropin), platelets, AST (aspartate transaminase), ALT (alanine transaminase), GGT (gamma-glutamyltransferase), and systolic and diastolic blood pressure levels. The gene discussed is GPT; the disease is type 2 diabetes mellitus.